Education
About Us
Working with TipRanks
Follow Us
Neurones (FR:NRO)
:NRO
Total Valuation
Neurones has a market cap or net worth of €1.13B. The enterprise value is €810.23M.
Market Cap€1.13B
Enterprise Value€810.23M
Share Statistics
Neurones has 24,278,715 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,278,715
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neurones’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.00%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)12.00%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee108.22K
Profits Per Employee8.55K
Employee Count6,849
Asset Turnover1.10
Inventory Turnover556.30
Valuation Ratios
The current PE Ratio of Neurones is 21.14. Neurones’s PEG ratio is 1.93.
PE Ratio21.14
PS Ratio1.38
PB Ratio2.95
Price to Fair Value2.95
Price to FCF19.31
Price to Operating Cash Flow14.49
PEG Ratio1.93
Income Statement
In the last 12 months, Neurones had revenue of 741.17M and earned 49.41M in profits. Earnings per share was 2.03.
Revenue741.17M
Gross Profit346.76M
Operating Income75.86M
Pretax Income80.77M
Net Income49.41M
EBITDA96.63M
Earnings Per Share (EPS)2.03
Cash Flow
In the last 12 months, operating cash flow was 62.18M and capital expenditures -19.27M, giving a free cash flow of 42.91M billion.
Operating Cash Flow62.18M
Free Cash Flow42.91M
Free Cash Flow per Share1.77
Dividends & Yields
Neurones pays an annual dividend of €1.2, resulting in a dividend yield of 2.55%
Dividend Per Share€1.2
Dividend Yield2.55%
Payout Ratio46.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change5.44%
50-Day Moving Average47.80
200-Day Moving Average44.98
Relative Strength Index (RSI)44.89
Average Volume (3m)3.99K
Important Dates
Neurones upcoming earnings date is Sep 10, 2025, TBA Not Confirmed.
Last Earnings DateMar 5, 2025
Next Earnings DateSep 10, 2025
Ex-Dividend DateJun 12, 2024
Financial Position
Neurones as a current ratio of 2.38, with Debt / Equity ratio of 13.36%
Current Ratio2.38
Quick Ratio2.38
Debt to Market Cap<0.01
Net Debt to EBITDA-2.63
Interest Coverage Ratio52.90
Taxes
In the past 12 months, Neurones has paid 22.18M in taxes.
Income Tax22.18M
Effective Tax Rate0.27
Enterprise Valuation
Neurones EV to EBITDA ratio is 8.18, with an EV/FCF ratio of 14.62.
EV to Sales1.07
EV to EBITDA8.18
EV to Free Cash Flow14.62
EV to Operating Cash Flow10.97
Balance Sheet
Neurones has €268.12M in cash and marketable securities with €102.00K in debt, giving a net cash position of -€221.39M billion.
Cash & Marketable Securities€268.12M
Total Debt€102.00K
Net Cash-€221.39M
Net Cash Per Share-€9.12
Tangible Book Value Per Share€14.65
Margins
Gross margin is 47.41%, with operating margin of 10.23%, and net profit margin of 6.67%.
Gross Margin47.41%
Operating Margin10.23%
Pretax Margin10.90%
Net Profit Margin6.67%
EBITDA Margin13.04%
EBIT Margin10.89%
Analyst Forecast
The average price target for Neurones is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―